市場調査レポート
商品コード
1298770
生体活性材料市場:材料、タイプ、用途、地域別2023-2028年Bioactive Materials Market by Material (Glass, Glass-ceramics, Composite, and Others), Type (Powder, Moldable, Granules, and Others), Application (Dentistry, Surgery, Bioengineering, and Others), and Region 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
生体活性材料市場:材料、タイプ、用途、地域別2023-2028年 |
出版日: 2023年06月14日
発行: IMARC
ページ情報: 英文 150 Pages
納期: 2~3営業日
|
生体活性材料の世界市場規模は2022年に25億1,000万米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて13.10%の成長率(CAGR)を示し、2028年までに56億1,000万米ドルに達すると予測しています。再生医療に対する需要の高まり、特性を向上させた新しい生体活性材料の市場開拓、バイオテクノロジーとライフサイエンスの分野における継続的な改善が、市場を牽引する主な要因となっています。
生体活性材料は、細胞、組織、臓器などの生体システムと相互作用することを意図した成分です。これらの材料は合成でも天然でもよく、主に組織工学、ドラッグデリバリー、再生医療など、さまざまな医療用途で使用されています。これらの材料は、標的とする組織の細胞外マトリックス(ECM)を模倣することにより、細胞接着、増殖、分化などの特定の生物学的応答を促進することができます。さらに、ドラッグデリバリーにも利用することができ、この場合、材料は時間の経過とともに薬物や治療薬を放出するように設計されています。これは、薬物が患部組織に直接放出され、副作用を最小限に抑え、有効性を向上させる標的ドラッグデリバリーに有用です。その結果、生体活性材料は医療分野で幅広い用途を持ち、様々な疾患や症状の治療を進めるための重要なツールであることから、世界中で広く注目されるようになっています。一般的な生体活性材料には、ハイドロキシアパタイトやポリカプロラクトン(PCL)などがあり、骨移植や歯科インプラントに広く採用されているほか、新しい組織の成長を促進する足場を作るのにも使われています。
世界市場は、患者やヘルスケア専門家の間で再生医療に対する需要が高まっていることが主な要因となっています。個人における慢性疾患の有病率の増加と相まって、革新的な治療オプションに対するニーズが高まっており、これが組織の再生と修復を促進するための生体活性材料の需要を後押ししています。これとともに、生体活性材料の分野における継続的な技術進歩や、生体適合性、生分解性、機械的強度などの特性が強化された新規・改良材料の開拓が、市場の明るい見通しを生み出しています。さらに、新しい材料や用途を開発するための広範な研究開発(R&D)活動への投資が増加していることも、成長を促す要因となっています。これとは別に、全体的なヘルスケア・インフラをアップグレードするための民間および公的機関による資金提供の増加が、市場に好影響を与えています。これとともに、バイオテクノロジーとライフサイエンスの分野における継続的な改善が、世界中の生体活性材料の需要を大きく支えています。急速な都市化、老人人口の増加、地方や地理的に拡大した場所での医療施設の開拓など、その他の要因も市場にプラスの影響を与えています。
The global bioactive materials market size reached US$ 2.51 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.61 Billion by 2028, exhibiting a growth rate (CAGR) of 13.10% during 2023-2028. The growing demand for regenerative medicine, the development of new and improved bioactive materials with enhanced properties and continuous improvements in the field of biotechnology and life science represent some of the key factors driving the market.
Bioactive materials are constituents that are meant to interact with biological systems, such as cells, tissues, and organs. These materials can be synthetic or natural and are mainly used in a variety of medical applications, including tissue engineering, drug delivery, and regenerative medicine. They can promote specific biological responses, such as cell adhesion, proliferation, and differentiation, by mimicking the extracellular matrix (ECM) of the tissue being targeted. Additionally, they can also be utilized for drug delivery, where the material is designed to release a drug or therapeutic agent over time. This can be useful for targeted drug delivery, where the drug is released directly to the affected tissue, minimizing side effects and improving efficacy. As a result, they are gaining widespread prominence across the globe since bioactive materials have a wide range of applications in the medical field and are an important tool for advancing treatments for various diseases and conditions. Some of the common bioactive materials include hydroxyapatite and polycaprolactone (PCL) that are widely adopted for bone grafts and dental implants and to create scaffolds that promote the growth of new tissue.
The global market is majorly driven by the growing demand for regenerative medicine among patients and healthcare professionals. Coupled with the increasing prevalence of chronic diseases among individuals, leading to a growing need for innovative treatment options, this is providing a boost to the demand for bioactive materials to promote tissue regeneration and repair. Along with this, continual technological advancements in the field of bioactive materials and the development of new and improved materials with enhanced properties, such as biocompatibility, biodegradability, and mechanical strength, are creating a positive market outlook. Furthermore, the growing investments in extensive research and development (R&D) activities to develop new materials and applications are acting as a growth-inducing factor. Apart from this, the escalating funding by private and public agencies to upgrade the overall healthcare infrastructure is impacting the market favorably. Along with this, continuous improvements in the field of biotechnology and life science are significantly supporting the demand for bioactive materials across the globe. Other factors, including rapid urbanization, the growing geriatric population and the development of medical facilities across rural and geographically extended locations, are also positively influencing the market.
IMARC Group provides an analysis of the key trends in each segment of the global bioactive materials market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on material, type and application.
Glass
Glass-ceramics
Composite
Others
The report has provided a detailed breakup and analysis of the bioactive materials market based on the material. This includes glass, glass-ceramics, composites and others. According to the report, glass represented the largest segment.
Powder
Moldable
Granules
Others
A detailed breakup and analysis of the bioactive materials market based on the type has also been provided in the report. This includes powder, moldable, granules and others. According to the report, powder type accounted for the largest market share.
Dentistry
Surgery
Bioengineering
Others
The report has provided a detailed breakup and analysis of the bioactive materials market based on the application. This includes dentistry, surgery, bioengineering and others. According to the report, dentistry application exhibits a clear dominance in the market.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for bioactive materials. Some of the factors driving the North America bioactive materials market included the growing investment in extensive research and development (R&D) activities, the emerging healthcare infrastructure, the development of medical facilities across rural and geographically extended locations, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global bioactive materials market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Arthrex Inc., BBS-Bioactive Bone Substitutes Oyj, Berkeley Advanced Biomaterials, Biomatlante SAS (Advanced Medical Solutions Group Plc), Ceraver, DePuy Synthes Inc. (Johnson & Johnson), Noraker, PULPDENT Corporation, Regenity Biosciences, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.